Literature DB >> 27245506

Prostate cancer: SRRM4 drives NEPC progression.

Rebecca Kelsey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27245506     DOI： 10.1038/nrurol.2016.102

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition.

Authors:  Yinan Li; Nilgun Donmez; Cenk Sahinalp; Ning Xie; Yuwei Wang; Hui Xue; Fan Mo; Himisha Beltran; Martin Gleave; Yuzhuo Wang; Colin Collins; Xuesen Dong
Journal:  Eur Urol       Date:  2016-05-11       Impact factor: 20.096
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.